earli
high
intraven
dose
vitamin
c
prevent
treat
coronaviru
diseas
pandem
first
report
wuhan
china
spread
mani
contin
countri
caus
sever
public
health
burden
current
vaccin
specif
antivir
drug
deadli
diseas
quick
deploy
access
effect
safe
treatment
urgent
need
save
live
curtail
spread
acut
respiratori
distress
syndrom
ard
key
factor
fatal
significantli
increas
oxid
stress
due
rapid
releas
free
radic
cytokin
hallmark
ard
lead
cellular
injuri
organ
failur
death
earli
use
larg
dose
antioxid
vitamin
c
vc
may
becom
effect
treatment
patient
clinic
studi
also
show
highdos
oral
vc
provid
certain
protect
viral
infect
neither
intraven
oral
administr
highdos
vc
associ
signific
side
effect
therefor
regimen
includ
treatment
use
prevent
measur
suscept
popul
healthcar
worker
higher
exposur
risk
coronavirus
influenza
among
pandem
virus
caus
lethal
lung
injuri
death
ard
viral
infect
could
evok
cytokin
storm
lead
lung
capillari
endotheli
cell
activ
neutrophil
infiltr
increas
oxid
stress
reactiv
oxygen
nitrogen
speci
ard
characterist
sever
hypoxemia
usual
accompani
uncontrol
inflamm
oxid
injuri
damag
alveolarcapillari
barrier
increas
oxid
stress
major
insult
pulmonari
injuri
includ
acut
lung
injuri
ali
ard
two
clinic
manifest
acut
respiratori
failur
substanti
high
morbid
mortal
report
patient
pneumonia
show
increas
hscrp
marker
inflamm
oxid
stress
transcript
factor
nuclear
factor
erythroid
relat
factor
major
regul
antioxid
respons
element
driven
cytoprotect
protein
express
activ
signal
play
essenti
role
prevent
cell
tissu
injuri
induc
oxid
stress
vc
import
compon
cellular
antioxid
system
benefici
critic
care
manag
cytokin
storm
observ
viral
bacteri
infect
result
increas
oxid
stress
via
common
nonspecif
pathway
sinc
prevent
manag
oxid
stress
could
realiz
larg
dose
antioxid
approach
may
applic
intraven
highdos
vc
base
outcom
three
previou
clinic
studi
involv
total
patient
sepsi
hemila
colleagu
report
variou
highdos
intraven
vc
infus
eg
mgkg
bodi
weightday
divid
dose
shorten
intens
care
unit
icu
stay
accompani
signific
reduct
mortal
rate
experi
reproduc
among
patient
ill
sever
influenza
inde
dietari
antioxid
vc
sulforaphan
shown
decreas
oxid
stress
induc
acut
inflammatori
lung
injuri
patient
receiv
mechan
ventil
addit
oral
vc
eg
g
daili
abl
reduc
viral
infect
risk
improv
symptom
highdos
intraven
vc
also
success
use
treatment
moder
sever
patient
china
dose
use
vari
g
g
per
day
given
period
h
addit
vc
bolu
may
requir
among
patient
critic
condit
oxygen
index
improv
real
time
patient
eventu
cure
discharg
fact
highdos
vc
clinic
use
sever
decad
recent
nih
expert
panel
document
state
clearli
regimen
gkg
bodi
weight
safe
without
major
advers
event
develop
efficaci
vaccin
antivir
drug
take
time
vc
antioxid
among
current
avail
agent
mitig
associ
ard
given
fact
highdos
vc
safe
healthcar
profession
take
close
look
opportun
obvious
welldesign
clinic
studi
absolut
need
develop
standard
protocol
bedsid
use
